Page last updated: 2024-08-22

clodronic acid and B-Cell Chronic Lymphocytic Leukemia

clodronic acid has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benner, A; Dürr, C; Egle, A; Gribben, JG; Hanna, BS; Kalter, V; Lichter, P; McClanahan, F; Rößner, PM; Seiffert, M; Yazdanparast, H; Zaborsky, N1
Anselmo, A; Barbaglio, F; Bertilaccio, MTS; Caligaris-Cappio, F; Cittaro, D; Corti, A; De Palma, M; Galletti, G; Ghia, P; Klein, C; Lazarevic, D; Ponzoni, M; Ranghetti, P; Riba, M; Ries, CH; Rocchi, M; Rodriguez, TV; Scarfò, L; Scielzo, C; Simonetti, G; van Rooijen, N1

Other Studies

2 other study(ies) available for clodronic acid and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
    Leukemia, 2016, Volume: 30, Issue:3

    Topics: Animals; Antigens, Ly; B7-H1 Antigen; Chemokine CXCL9; Clodronic Acid; Dendritic Cells; Disease Models, Animal; Gene Expression Regulation, Leukemic; Humans; Immunophenotyping; Interleukin-10; Leukemia, Lymphocytic, Chronic, B-Cell; Macrophages; Mice; Mice, Transgenic; Monocytes; Peritoneal Cavity; Phenotype; Receptors, CCR2; Signal Transduction; Spleen; T-Lymphocytes; Tumor Necrosis Factor-alpha

2016
Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression.
    Cell reports, 2016, Feb-23, Volume: 14, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Apoptosis; B-Lymphocytes; Cell Communication; Cell Line, Tumor; Clodronic Acid; Disease Progression; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Liposomes; Macrophages; Mice; Mice, Transgenic; Neoplasm Transplantation; Primary Cell Culture; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Signal Transduction; Survival Analysis; Transplantation, Heterologous; Tumor Microenvironment

2016